In agreement, humans with TLR4 mutations, which lead to reduced receptor signaling and depressed inflammatory response, are also less susceptible to atherosclerosis (Arbour et al., 2000; Kiechl et al., 2002; Lin et al., 2012). The gene discussed is TLR4; the disease is atherosclerosis.